1 insiders reported 17 Form 4 transactions for Greenwich LifeSciences, Inc. (GLSI) over the past 18 months (most recent 2026-07-30). Recent activity: Patel Snehal (CEO and CFO) Buy 700 shares, Patel Snehal (CEO and CFO) Buy 1,500 shares, Patel Snehal (CEO and CFO) Buy 1,500 shares, Patel Snehal (CEO and CFO) Buy 2,500 shares, Patel Snehal (CEO and CFO) Buy 1,100 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-30 | Patel Snehal | CEO and CFO | Buy | 700 | $9,170 |
| 2026-07-30 | Patel Snehal | CEO and CFO | Buy | 1,500 | $20,385 |
| 2026-07-29 | Patel Snehal | CEO and CFO | Buy | 1,500 | $20,430 |
| 2026-07-27 | Patel Snehal | CEO and CFO | Buy | 2,500 | $32,850 |
| 2026-07-27 | Patel Snehal | CEO and CFO | Buy | 1,100 | $14,168 |
| 2026-01-15 | Patel Snehal | CEO and CFO | Buy | 1,800 | $53,694 |
| 2026-01-14 | Patel Snehal | CEO and CFO | Buy | 2,900 | $79,866 |
| 2026-01-05 | Patel Snehal | CEO and CFO | Buy | 4,300 | $91,848 |
| 2026-01-02 | Patel Snehal | CEO and CFO | Buy | 2,900 | $63,017 |
| 2025-12-19 | Patel Snehal | CEO and CFO | Buy | 4,100 | $51,742 |
| 2025-11-28 | Patel Snehal | CEO and CFO | Buy | 4,600 | $38,502 |
| 2025-11-12 | Patel Snehal | CEO and CFO | Buy | 10,600 | $89,358 |
| 2025-11-04 | Patel Snehal | CEO and CFO | Buy | 2,300 | $21,298 |
| 2025-04-29 | Patel Snehal | CEO and CFO | Buy | 3,600 | $35,568 |
| 2025-04-22 | Patel Snehal | CEO and CFO | Buy | 5,400 | $48,492 |
| 2025-04-08 | Patel Snehal | CEO and CFO | Buy | 3,600 | $32,760 |
| 2025-04-07 | Patel Snehal | CEO and CFO | Buy | 5,500 | $48,015 |
Source: SEC Form 4 filings · as of 2026-07-30